Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 29,600 AVIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| Jun 12, 2026 | Celcuity Inc. (CELC) | Gift | 14,048 | n/a |
| Jun 9, 2026 | Celcuity Inc. (CELC) | Grant/Award | 1,530 | n/a |
| May 21, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Purchase | 6,100 | $25.4K |
| Jun 24, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 29,600 | n/a |
| May 29, 2025 | Celcuity Inc. (CELC) | Gift | 16,300 | n/a |
| May 21, 2025 | Celcuity Inc. (CELC) | Grant/Award | 14,048 | n/a |
| Jun 21, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 29,600 | n/a |
| Jun 18, 2024 | Atea Pharmaceuticals, Inc. (AVIR) | Exercise/Conversion | 33,150 | n/a |
| Jun 6, 2024 | Celcuity Inc. (CELC) | Grant/Award | 8,153 | n/a |